| HALL A |
| 09:30-14:00 | TRANSFORMATIVE PRECISION CANCER DIAGNOSTICS AND THERAPIES |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Ofer Sharon, MD, CEO, OncoHost |
| 09:30 - 09:35 | Opening Remarks: Ofer Sharon, MD, CEO, OncoHost, "Precision medicine challenges and opportunities" |
| 09:35 - 09:45 | Prof. Dror Harats, MD, CEO, VBL Therapeutics, "New Treatment strategies for Solid Tumors: major Leaps, but still work to be done" |
| 09:45 - 10:00 | Prof. Dror Harats, MD, CEO, VBL Therapeutics |
10:00 - 10:15
| Roni Mamluk, PhD, Founder and CEO, Ayala Pharma |
| 10:15 - 10:30 | Isaac Israel, CEO, Purple Biotech |
| 10:30 - 10:45 | Ilana Mandel, PhD, VP, R&D, Biond Biologics |
| 10:45 - 11:00 | Eran Ophir, PhD, VP Research and Drug Discovery, Compugen |
| 11:30 - 12:00 | Reddy Prasanth, MD, SVP, Global Enterprise Oncology Head, Covance/Labcorp Drug Development |
| 12:00 - 12:15 | Ronen Eavri, PhD, Co-founder and CEO, Barcode Nanotech Next Generation Therapeutics |
| 12:15 - 12:30 | Ofer Sharon, MD, CEO, OncoHost |
| 12:30 - 12:45 | Avi Veidman, Co-founder and CEO, Nucleai |
| 12:45 - 13:00 | Vered Bar, PhD, VP, R&D, Curesponse |
| 13:00 - 13:15 | Inbal Zafir-Lavie, PhD, CEO and Co-founder, Gina Life |
| 13:15 - 13:30 | Roi Feingersch, PhD, CEO and Founder, FORESEE GENOMICS |
| 13:30 - 13:45 | Assaf Halevy, Founder and CEO, 2bPrecise, Genomics and Precision Medicine |
| 14:00 - 15:00 | Lunch Break |
| HALL B |
| 09:30-14:00 | DIGITAL RECONSTRUCTION OF HEALTHCARE |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel |
| 09:30 - 09:35 | Opening Remarks: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel |
| 09:35 - 09:55 | Guy Spigelman, EMEA Lead Healthcare and Life Sciences Startups, Amazon Web Services (AWS), "How Big Tech and High Performance Computing will Impact Healthcare and Life Sciences" |
| 09:55 - 10:15 | Elliot Menschik, MD, PhD, CDO, Resilience, "Software-defined biomanufacturing of therapeutics" |
| 10:15 - 10:30 | Avinatan Hassidim, Head of Google Israel research group, Google, "Reimagining the medical record" |
| 10:30 - 10:45 | Prof. Sam Shah, PhD, Chief Medical Strategy Officer, Numan, "Digital first: building a full stack health provider inside and outside the NHS" |
| 10:45 - 11:00 | Dedi Gilad, CEO and Co-founder, TytoCare, "The state of virtual care industry in the post-COVID era," Fireside chat with: Anat Naschitz, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel |
| 11:30 - 11:45 | Amnon Bar Lev, Co-founder and CEO, Alike.Health |
| 11:45 - 12:00 | Kira Radinsky, PhD, Founder, CEO and CTO, Diagnostic Robotics |
| 12:00 - 12:15 | Anat Naschitz, Founder and CEO, 9xchange,; Co-founder, OrbiMed Israel, "9xchange, molecule marketplace" |
| 12:15 - 12:30 | Amir Trabelsi, Co-founder and CEO, Genoox |
| 12:30 - 12:45 | Orr Inbar, Co-founder and CEO, QuantHealth |
| 12:45 - 13:00 | Israel (Srulik) Dvorsky, Co-founder and CEO, TailorMed |
| 13:00 - 13:15 | Itai Gueta, MD, Institue of Clinical Pharmacology, Sheba Tel Ha Shomer Medical Center, "MDCIone - customer perspective" |
| 13:15 - 13:30 | Eliran Malki, Co-founder and CEO, Belong.Life |
| 13:30 - 13:45 | Chris Guiffre, CFO and COO, Pear Therapeutics "ZOOM" |
| 14:00 - 15:00 | Lunch Break |
| HALL C |
| 09:30 - 14:00 | INFECTIOUS DISEASES - BREAKING BARRIERS IN VACCINE DEVELOPMENT, THERAPY AND DIAGNOSIS MODALITIES |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital |
| 09:35 - 09:55 | Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital, "Covid19, where are we going?" |
| 10:00 - 10:20 | BARRY GREENE, CEO, Sage Therapeutics, USA, "COVID exacerbating mental health issues," |
| 10:20 - 10:40 | Prof. Jacob Strahilevitz, MD, Head of the department of Infectious Diseases and Clinical Microbiology, Hadassah Medical Center, "Antimicrobial stewardship: A societal need to combat resistance" |
| 10:40 - 11:00 | Prof. Ronen Ben Ami, MD, Head of the Infectious Diseases Unit, Tel Aviv Medical Center, "Emerging Fungal Threats in 2022" |
| 11:30 - 11:45 | Nadav Ben-Dov, PhD, CEO and Co-founder, phenofAST |
| 11:45 - 12:00 | Eynat Finkelshtein, PhD, CSO, Code Pharma |
| 12:00 - 12:15 | Moshik Cohen-Kutner, PhD, CEO, Omnix Medical |
| 12:15 - 12:30 | Jonathan Solomon, CEO and Board Member, Biomx |
| 12:30 - 12:45 | Nadav Kidron, CEO and Chairman of the Board, Oravax Medical |
| 12:45 - 13:00 | Einat Galamidi Cohen, MD, VP Medical, Enlivex Therapeutics |
| 13:00 - 13:15 | Ofer Chen, MD, VP Clinical Development, Clew Medical |
| 13:15 - 13:30 | Yotam Levin, MD, CEO, NanoPass |
| 13:30 - 13:45 | Eddie Sadan, Co-founder, Terrapeutics |
| 13:45 - 14:00 | Tamar Ben-Yedida, PhD, CSO, BiondVax Pharmaceuticals |
| 14:00 - 15:00 | Lunch Break |
| PLENARY SESSION |
| 15:15 - 15:45 | Alban de la Sabliere, SVP, Head of Sanofi Partnering Sanofi, France, "Sanofi: Implementing a Play to a Win Strategy" |
| 15:45 - 16:15 | Ehud Rivlin, PhD, Israel Site Lead Verily, Israel |
| 16:15 - 16:45 | Tal Zaks, MD, PhD, Venture Partner, Orbimed, USA, "ZOOM" |
